Home › Psoriasis › NCT07489885
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
RecruitingPhase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Who can join
Ages 18 to 70 · All sexes
Full eligibility criteria
Inclusion Criteria: * Participants with a diagnosis of plaque psoriasis with no significant flares of disease activity for at least 6 months before signing the informed consent * Participants have moderate to severe plaque psoriasis as defined by a total body surface area (BSA) ≥10%, a Psoriasis Area and Severity Index (PASI) score ≥ 12 and a Physician's Global Assessment (PGA) score ≥ 3. * Within normal ranges of laboratory assessments Exclusion Criteria: * Any comorbidities or past medical conditions as outlined in the protocol that would interfere with study assessments as deemed by the Investigator
About the study
A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis
What is being tested
- D-2570 Tablet (drug)
- Placebo Tablets (drug)
Sponsor: InventisBio Co., Ltd · Participants: 75 · Started: Jun 3, 2026
Contact the study team
- Kathryn Stazzone · Phone: 3025195966
Official record on ClinicalTrials.gov — NCT07489885
Locations in the U.S.
| Alabama | Study Center, Birmingham |
| Arizona | Study Center, Phoenix (Not yet recruiting) |
| California | Study Center, Chula Vista Study Center, Fountain Valley (Not yet recruiting) Study Center, Fremont (Not yet recruiting) Study Center, Los Angeles (Not yet recruiting) Study Center, Los Angeles (Not yet recruiting) Study Center, San Diego (Not yet recruiting) |
| Florida | Study Center, Fort Lauderdale (Not yet recruiting) Study Center, Miramar (Not yet recruiting) Study Center, Ocala (Not yet recruiting) Study Center, Tampa (Not yet recruiting) |
| Georgia | Study Center, Sandy Springs (Not yet recruiting) Study Center, Savannah (Not yet recruiting) |
| Idaho | Study Center, Idaho Falls (Not yet recruiting) |
| Indiana | Study Center, Clarksville (Not yet recruiting) |
| Kentucky | Study Center, Louisville (Not yet recruiting) |
| Ohio | Study Center, Mayfield Heights (Not yet recruiting) |
| Pennsylvania | Study Center, Philadelphia (Not yet recruiting) |
| Texas | Study Center, San Antonio |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.